Contrasting effects of pituitary adenylate cyclase activating polypeptide (PACAP) on in vivo and in vitro prolactin and growth hormone release in male rats.

[1]  R. Macleod,et al.  Induction of interleukin-6 release by interleukin-1 in rat anterior pituitary cells in vitro: evidence for an eicosanoid-dependent mechanism. , 1991, Endocrinology.

[2]  W. Creutzfeldt,et al.  Characterization of a guanosine-nucleotide-binding-protein-coupled receptor for pituitary adenylate-cyclase-activating polypeptide on plasma membranes from rat brain. , 1991, European journal of biochemistry.

[3]  M. Culler,et al.  Pituitary adenylate cyclase-activating polypeptide (PACAP) potentiates the gonadotropin-releasing activity of luteinizing hormone-releasing hormone. , 1991, Endocrinology.

[4]  K. Mizuno,et al.  Neuropeptide regulation of interleukin-6 production from the pituitary: stimulation by pituitary adenylate cyclase activating polypeptide and calcitonin gene-related peptide. , 1991, Endocrinology.

[5]  M. Szabo,et al.  Somatostatin partially impedes the stimulatory effects of thyrotrophin-releasing hormone and dibutyryl cyclic AMP on prolactin release: prolactin release through multiple routes. , 1991, The Journal of endocrinology.

[6]  A. Arimura,et al.  Immunohistochemical demonstration of a novel hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide, in the ovine hypothalamus. , 1990, Endocrinology.

[7]  I. Tatsuno,et al.  Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide. , 1990, Endocrinology.

[8]  H. Onda,et al.  A novel peptide which stimulates adenylate cyclase: molecular cloning and characterization of the ovine and human cDNAs. , 1990, Biochemical and biophysical research communications.

[9]  M. Culler,et al.  Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. , 1989, Biochemical and biophysical research communications.

[10]  B. Brown,et al.  Evidence that angiotensin II is a paracrine agent mediating gonadotrophin-releasing hormone-stimulated inositol phosphate production and prolactin secretion in the rat. , 1988, The Journal of endocrinology.

[11]  W. Ganong,et al.  Evidence that the gonadotrophs are the likely site of production of angiotensin II in the anterior pituitary of the rat. , 1986, Endocrinology.

[12]  C. Denef.  Paracrine interactions in the anterior pituitary. , 1986, Clinics in endocrinology and metabolism.

[13]  J. D. Neill,et al.  Detection and measurement of secretion from individual neuroendocrine cells using a reverse hemolytic plaque assay. , 1986, Methods in enzymology.

[14]  J. D. Neill,et al.  Detection of hormone release from individual cells in mixed populations using a reverse hemolytic plaque assay. , 1983, Endocrinology.

[15]  C. Denef,et al.  Evidence for paracrine interaction between gonadotrophs and lactotrophs in pituitary cell aggregates. , 1983, Endocrinology.

[16]  D. Bataille,et al.  Vasoactive intestinal peptide (VIP) stimulates prolactin (PRL) release and cAMP production in a rat pituitary cell line (GH3/B6). Additive effects of VIP and TRH on PRL release , 1979, FEBS letters.

[17]  S. Ojeda,et al.  A rapid and simple procedure for chronic cannulation of the rat jugular vein. , 1974, Journal of applied physiology.